BNP Paribas’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$58.6K Buy
825
+500
+154% +$39.4K ﹤0.01% 263
2025
Q4
$26.7K Sell
325
-835
-72% -$65.1K ﹤0.01% 289
2025
Q3
$87K Sell
1,160
-188
-14% -$14K ﹤0.01% 246
2025
Q2
$99.9K Buy
1,348
+1,087
+416% +$75.7K ﹤0.01% 249
2025
Q1
$21.9K Sell
261
-100
-28% -$8.59K ﹤0.01% 290
2024
Q4
$28.2K Buy
361
+56
+18% +$4.76K ﹤0.01% 303
2024
Q3
$28.5K Buy
305
+7
+2% +$588 ﹤0.01% 288
2024
Q2
$23.2K Sell
298
-32
-10% -$2.61K ﹤0.01% 271
2024
Q1
$30K Buy
+330
New +$27.5K ﹤0.01% 276

Other funds holding GEHC

BNP Paribas's GEHC Position: Q1 2026 in Review

BNP Paribas increased its GE HealthCare (GEHC) stake by 154% in Q1 2026, buying an estimated $39.4K and bringing the position to 825 shares worth $58.6K. The position accounts for ﹤0.01% of the portfolio, ranked #263.

BNP Paribas first reported a position in GEHC in Q1 2024 and has held it in 9 quarters since. The position peaked at $99.9K in Q2 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • BNP Paribas held 825 shares of GE HealthCare worth $58.6K as of Q1 2026.
  • BNP Paribas bought 500 GE HealthCare shares in Q1 2026, an estimated $39.4K.
  • GE HealthCare made up ﹤0.01% of BNP Paribas's portfolio in Q1 2026, its #263 holding.
  • BNP Paribas first reported a position in GE HealthCare in Q1 2024 and has held it in 9 quarters since.
  • BNP Paribas's GE HealthCare position peaked at $99.9K in Q2 2025.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.